[1]
Eshmuratov Sardor Eldorovich and Uralov Rustam Sherbekovich 2024. THE CLINICAL SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA. Spectrum Journal of Innovation, Reforms and Development. 27, (May 2024), 51–58.